Status:
UNKNOWN
Using Text Messages to Improve COVID-19 Vaccination Uptake
Lead Sponsor:
Imperial College Healthcare NHS Trust
Collaborating Sponsors:
Central London CCG
Imperial College Health Partners
Conditions:
Covid19
Eligibility:
All Genders
18-49 years
Phase:
NA
Brief Summary
COVID-19 vaccinations significantly reduce the risk of getting seriously ill or dying from COVID-19. Since December 2020, the UK has rolled out vaccinations according to the Joint Committee for Vaccin...
Detailed Description
The COVID-19 vaccine is an effective way to reduce morbidity and mortality from COVID-19. Increasing uptake of the COVID-19 vaccine is a major public health priority. People's willingness to receive t...
Eligibility Criteria
Inclusion
- Residents registered with a GP practice in the Central London (Westminster) Clinical Commissioning Group (CCG)
- Age 18-49
- Not previously invited for COVID-19 vaccination
Exclusion
- Patients who have notified their GP that they wish to decline the COVID-19 vaccination.
- Patients' whose medical records report a severe allergy to medicines (as per the JCVI guidance)
Key Trial Info
Start Date :
May 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 11 2022
Estimated Enrollment :
120000 Patients enrolled
Trial Details
Trial ID
NCT04895683
Start Date
May 11 2021
End Date
May 11 2022
Last Update
May 24 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.